Professor Christopher Griffiths BSc, MB, BS, MD,FRCP,FRCP(Edin), FRCPath, FMedSci

Photograph of Christopher Griffiths

Foundation Professor of Dermatology, Faculty of Medical and Human Sciences

Biography

Chris Griffiths gained a 1st class hons BSc in Anatomy and qualified in Medicine from St Thomas’ Hospital Medical School, London University. He  trained in Dermatology at St Mary’s Hospital, London, and at the University of Michigan, USA, where he was also on Faculty for 4 years.  He was appointed to the Foundation Chair in Dermatology at the University of Manchester in 1994 and is an honorary consultant dermatologist at Salford Royal NHS Foundation Trust. Professor Griffiths developed  the ‘hub-and-spoke’ model of dermatology services for Greater Manchester, and introduced a multidisciplinary clinic for severe psoriasis – the Manchester Psoriasis Service – awarded Hospital Doctor Dermatology Team of the Year in 2002. At the University of Manchester he has served variously as: Head of Medicine and Neuroscience; Head of the School of Translational Medicine; Associate  Dean for Research and; Director of the Manchester Academic Health Science Centre.

Professor Griffiths’ named lectureships include:  Sydney Watson Smith  (2006); Parkes Weber (2007); Von Zumbusch,  Munich (2008) and; Hellerstrom, Stockholm (2010). He is  co-founder of the International Psoriasis Council and is its President-Elect. He received the psoriasis  lifetime achievement award of the American Skin Association in 2009.  The Times of London named him as one of the UK’s Top 200 doctors in 2010 and in 2011 he was appointed as an NIHR Senior Investigator and elected to Fellowship of the Academy of Medical Sciences.

Professor Griffiths has been President of :the British Association of Dermatologists (2004-5); European Dermatology Forum (2010-11) and; British Society for Investigative Dermatology (1997-2000). He serves on the editorial boards of eight scientific journals and is an Associate Editor of the Journal of Investigative Dermatology. He  has published 458 Pubmed cited articles in scientific journals, has an H-Index of 73 and is lead editor of Rook’s Textbook of Dermatology.   His research includes immunological mechanisms of psoriasis, where he has been instrumental in development of the new biologics, immunotherapy (including the new biological agents), the “brain-skin axis” and mechanisms and repair of skin ageing, particularly topical retinoids.

Publications

2099

  • Ennis, H., Herrick, A. L., Cassidy, C., Griffiths, C. E. M., & Richards, H. L. (2099). A pilot study of body image dissatisfaction and the psychological impact of systemic sclerosis-related telangiectases.Clinical and Experimental Rheumatology, 31(2 Suppl 76).
    . Publication link: cfb4c8dd-441b-48f2-a690-46c04a0ab5d4 | PubMed:23324653
  • Griffiths, C. E. M. (2099). Leukocyte extravasation as a target for anti-inflammatory therapies in dermatology: which molecular target is best?. Exp Derm.
    . Publication link: 51cf56b6-2ff9-4980-9eb1-f863c14de2b3
  • Griffiths, C., Griffiths, T. W., & Griffiths, C. E. M. (2099). Cosmeceuticals.Skinmed, 10(5).
    . Publication link: 28f3928a-b2d4-4a03-897c-26d166abbad4 | PubMed:23163068

2016

2015

  • Bakkour, W., Purssell, H., Chinoy, H., Griffiths, C. E. M., & Warren, R. B. (2015). The risk of post-operative complications in psoriasis and psoriatic arthritis patients on biologic therapy undergoing surgical procedures.Journal of the European Academy of Dermatology and Venereology : JEADV, 30(1), 86-91. DOI:10.1111/jdv.12997
    . Publication link: af95e978-944e-4e56-a2ef-5ec2e970afa5 | PubMed:25732669
  • Berki, D. M., Liu, L., Choon, S-E., David Burden, A., Griffiths, C. E. M., Navarini, A. A., ... Barker, J. N. (2015). Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.The Journal of investigative dermatology, 135(12). DOI:10.1038/jid.2015.288
    . Publication link: c2ad13fa-3e6a-4074-91f2-46edd21b4ead | PubMed:26203641
  • Bissonnette, R., Iversen, L., Sofen, H., Griffiths, C. E. M., Foley, P., Romiti, R., ... Wolk, R. (2015). Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial.The British journal of dermatology, 172(5). DOI:10.1111/bjd.13551
    . Publication link: 290b7d8b-c030-4c61-ab23-be9d091be4ad | PubMed:25418186
  • Chisholm, A., Nelson, P. A., Pearce, C. J., Keyworth, C., Griffiths, C. E. M., Cordingley, L., ... Griffiths, C. E. M. (2015). The role of personal models in clinical management: Exploring health care providers’ beliefs about psoriasis. British Journal of Health Psychology. DOI:10.1111/bjhp.12148
    . Publication link: d617dddc-6993-4e48-becf-20a596ff0395 | PubMed:26223822
  • Eaton, L. H., Kimber, I., & Griffiths, C. E. M. (2015). A fresh look at T cells in psoriasis.The British journal of dermatology, 173(4). DOI:10.1111/bjd.14099
    . Publication link: a2b925ed-5b92-4389-bbbc-612353684c44 | PubMed:26511827
  • Ellingford, J. M., Black, G. C. M., Clayton, T. H., Judge, M., Griffiths, C. E. M., & Warren, R. B. (2015). A novel mutation in IL36RN underpins childhood pustular dermatosis.Journal of the European Academy of Dermatology and Venereology : JEADV. DOI:10.1111/jdv.13034
    . Publication link: 98a6ad05-6bb1-4566-af09-97edb75ccdea | PubMed:25688670
  • Griffiths, C. E. M., Lebwohl, M., van de Kerkhof, P., Menter, A., Cameron, G. S., Erickson, J., ... Magarinos, G. A. (2015). Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.Lancet (London, England), 386(9993). DOI:10.1016/S0140-6736(15)60125-8
    . Publication link: 5c04afbb-f9b1-4f83-b38f-df20bdfda055 | PubMed:26072109
  • Griffiths, C. E. M., Luger, T. A., Brault, Y., Germain, J. M., & Mallbris, L. (2015). Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: results from the CRYSTEL study.Journal of the European Academy of Dermatology and Venereology : JEADV, 29(3). DOI:10.1111/jdv.12585
    . Publication link: 4b47257d-a608-45ae-aab8-37907eef13a6 | PubMed:25087839
  • Griffiths, C., Gunn, D. A., Dick, J. L., van Heemst, D., Griffiths, C. E. M., Tomlin, C. C., ... de Craen, A. J. M. (2015). Lifestyle and youthful looks.The British journal of dermatology, 172(5). DOI:10.1111/bjd.13646
    . Publication link: 19bb279a-2ab5-41dc-95c9-3ba073e647aa | PubMed:25627783
  • Hébert, H. L., Bowes, J., Smith, R. L., Flynn, E., Parslew, R., Alsharqi, A., ... Warren, R. B. (2015). Identification of loci associated with late-onset psoriasis using dense genotyping of immune-related regions.The British journal of dermatology, 172(4), 933-939. DOI:10.1111/bjd.13340
    . Publication link: fe1c9022-419a-4b31-adee-32058d445e7c | PubMed:25124732
  • Hibbert, S. A., Watson, R. E. B., Gibbs, N. K., Costello, P., Baldock, C., Weiss, A. S., ... Sherratt, M. J. (2015). A potential role for endogenous proteins as sacrificial sunscreens and antioxidants in human tissues.Redox biology, 5. DOI:10.1016/j.redox.2015.04.003
    . Publication link: c4f4eeb4-aed3-44c3-94f1-1b34300c463b | PubMed:25911998
  • Hollywood, K. A., Winder, C. L., Dunn, W. B., Xu, Y., Broadhurst, D., Griffiths, C. E. M., & Goodacre, R. (2015). Exploring the mode of action of dithranol therapy for psoriasis: a metabolomic analysis using HaCaT cells.Molecular BioSystems, 11(8). DOI:10.1039/c4mb00739e
    . Publication link: 059a66d5-4f45-4a3d-a274-f7775f5edfbf | PubMed:26018604
  • Iskandar, I. Y. K., Ashcroft, D. M., Smith, C. H., Griffiths, C. E. M., Warren, R. B., Yiu, Z. Z. N., ... Reynolds, N. J. (2015). Demographics and disease characteristics of psoriasis patients enrolled in the British Association of Dermatologists Biologic Interventions Register (BADBIR).The British journal of dermatology, 173(2), 510-518. DOI:10.1111/bjd.13908
    . Publication link: ae50de6e-db17-4e08-9df8-d25a465d9726 | PubMed:25989336
  • Jacobs, L. C., Hamer, M. A., Gunn, D. A., Deelen, J., Lall, J. S., van Heemst, D., ... Nijsten, T. (2015). A Genome-Wide Association Study Identifies the Skin Color Genes IRF4, MC1R, ASIP, and BNC2 Influencing Facial Pigmented Spots.The Journal of investigative dermatology, 135(7). DOI:10.1038/jid.2015.62
    . Publication link: 829fa801-0c06-40e1-89e2-ae97a16f0714 | PubMed:25705849
  • Jani, M., Chinoy, H., Warren, R. B., Griffiths, C. E. M., Plant, D., Fu, B., ... BRAGGSS., . U. (2015). Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis.Arthritis & rheumatology (Hoboken, N.J.), 67(8), 2011-2019. DOI:10.1002/art.39169
    . Publication link: 52a86356-e59d-468a-ade9-1cef4a97948e | PubMed:26109489
  • Jani, M., Chinoy, H., Warren, R. B., Griffiths, C. E. M., Plant, D., Morgan, A. W., ... Barton, A. (2015). Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis.Lancet (London, England), 385 Suppl 1. DOI:10.1016/S0140-6736(15)60363-4
    . Publication link: 7c902e19-1174-422f-ad50-fa7aa08df17f | PubMed:26312870
  • Keyworth, C., Nelson, P. A., Chew-Graham, C. A., Kane, K., Pearce, C. J., Griffiths, C. E. M., ... Griffiths, C. E. M. (2015). Communicating Cardiovascular Disease Risk to People with Psoriasis: What Techniques do Practitioners Use?. International journal of behavioral medicine. DOI:10.1007/s12529-015-9517-8
    . Publication link: 807c8760-e658-4cdd-9d13-c0bcc3d66d1a | PubMed:26490451
  • Keyworth, C., Nelson, P. A., Griffiths, C. E., Cordingley, L., Bundy, C., & Griffiths, C. E. M. (2015). Do English healthcare settings use 'Choice Architecture' principles in promoting healthy lifestyles for people with psoriasis? An observational study.BMC health services research, 15. DOI:10.1186/s12913-015-0808-1
    . Publication link: 71dbe8d7-ed7d-4d0f-a410-9313dc58b0f5 | PubMed:26032696
  • Kitchen, H., Cordingley, L., Young, H., Griffiths, C. E. M., & Bundy, C. (2015). Patient-reported outcome measures in psoriasis: the good, the bad and the missing!. The British journal of dermatology, 172(5). DOI:10.1111/bjd.13691
    . Publication link: bd551dd7-1cd0-4718-88b7-64e8647df71c | PubMed:25677764
  • Menter, M. A., & Griffiths, C. E. M. (2015). Psoriasis: the future.Dermatologic clinics, 33(1). DOI:10.1016/j.det.2014.09.012
    . Publication link: 4793e364-88ee-4f12-bebb-6681392d5511 | PubMed:25412790
  • Nelson, P. A., Kane, K., Chisholm, A., Pearce, C. J., Keyworth, C., Rutter, M. K., ... the, I. T. (2015). ‘I should have taken that further’ – missed opportunities during cardiovascular risk assessment in patients with psoriasis in UK primary care settings: a mixed-methods study. Health Expectations. DOI:10.1111/hex.12404
    . Publication link: ccfd0247-62c8-41c3-b6a4-e9aa9768820d | PubMed:26340682
  • Papp, K., Reich, K., Leonardi, C. L., Kircik, L., Chimenti, S., Langley, R. G. B., ... Griffiths, C. E. M. (2015). Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).Journal of the American Academy of Dermatology, 73(1). DOI:10.1016/j.jaad.2015.03.049
    . Publication link: 1118d077-1de8-4657-9d29-b4a5427010d8 | PubMed:26089047
  • Parisi, R., Rutter, M. K., Lunt, M., Young, H. S., Symmons, D. P. M., Griffiths, C. E. M., & Ashcroft, D. M. (2015). Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink.The Journal of investigative dermatology, 135(9), 2189-2197. DOI:10.1038/jid.2015.87
    . Publication link: 1bfefcab-7c1e-4c6e-9561-5ed9261523dc | PubMed:25742120
  • Schaefer, C., Mamolo, C., Cappelleri, J. C., Le, C., Daniel, S., Mallbris, L., & Griffiths, C. E. (2015). Disease Burden, Outcomes and Costs Among Adults Admitted To Hospital In The United Kingdom (Uk) Due to Plaque Or Erythrodermic Psoriasis.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 18(7). DOI:10.1016/j.jval.2015.09.579
    . Publication link: 3cdeaf07-ef31-495d-bdef-dbaa4c906f8e | PubMed:26532394
  • Tan, K-W., & Griffiths, C. E. (2015). Novel systemic therapies for the treatment of psoriasis.Expert opinion on pharmacotherapy. DOI:10.1517/14656566.2016.1109636
    . Publication link: 8781a3b9-81fd-4a3e-88dd-9ae76d85ab83 | PubMed:26548897
  • van Drielen, K., Gunn, D. A., Noordam, R., Griffiths, C. E. M., Westendorp, R. G. J., de Craen, A. J. M., & van Heemst, D. (2015). Disentangling the effects of circulating IGF-1, glucose, and cortisol on features of perceived age.Age (Dordrecht, Netherlands), 37(3). DOI:10.1007/s11357-015-9771-3
    . Publication link: cfe3c1aa-588a-4e73-b2d7-fe14ceed96f0 | PubMed:25874752
  • Waaijer, M. E. C., Gunn, D. A., Adams, P. D., Pawlikowski, J. S., Griffiths, C. E. M., van Heemst, D., ... Maier, A. B. (2015). P16INK4a Positive Cells in Human Skin Are Indicative of Local Elastic Fiber Morphology, Facial Wrinkling, and Perceived Age.The journals of gerontology. Series A, Biological sciences and medical sciences. DOI:10.1093/gerona/glv114
    . Publication link: 5f77e2f2-afe7-4217-9863-20dbc6644814 | PubMed:26286607
  • Warren, R. B., Smith, C. H., Yiu, Z. Z. N., Ashcroft, D. M., Barker, J. N. W. N., Burden, A. D., ... Griffiths, C. E. M. (2015). Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).The Journal of investigative dermatology, 135(11), 2632-2640. DOI:10.1038/jid.2015.208
    . Publication link: cded3aed-6bd6-410f-b41f-1c93ac24393b | PubMed:26053050
  • Yiu, Z. Z. N., Madan, V., & Griffiths, C. E. M. (2015). Acne conglobata and adalimumab: use of tumour necrosis factor-α antagonists in treatment-resistant acne conglobata, and review of the literature.Clinical and Experimental Dermatology, 40(4). DOI:10.1111/ced.12540
    . Publication link: cf21037e-1f6f-40cb-8109-7514bd9e3d21 | PubMed:25545016
  • Yiu, Z. Z. N., Warren, R. B., Mrowietz, U., & Griffiths, C. E. M. (2015). Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomes.The Journal of dermatological treatment, 26(4). DOI:10.3109/09546634.2014.991673
    . Publication link: fc5087d3-9670-4a43-8d46-c468ec5f48c0 | PubMed:25424052

2014

  • Al-Nuaimi, Y., Sherratt, M. J., & Griffiths, C. E. M. (2014). Skin health in older age.Maturitas, 79(3). DOI:10.1016/j.maturitas.2014.08.005
    . Publication link: 84a22b4f-0956-4eec-8e32-3f31a981850a | PubMed:25213594
  • Aslam, A., & Griffiths, C. E. M. (2014). Drug therapies in dermatology. Clinical Medicine, Journal of the Royal College of Physicians of London, 14(1), 47-53. DOI:10.7861/clinmedicine.14-1-47
    . Publication link: 27e4248d-9758-435b-af74-67019f1cd251 | PubMed:24532745
  • Aslam, A., Salam, A., Griffiths, C. E. M., & Mcgrath, J. A. (2014). Naevus sebaceus: A mosaic RASopathy. Clinical and Experimental Dermatology, 39(1), 1-6. DOI:10.1111/ced.12209
    . Publication link: 6ca2acad-cef7-4ed2-aa96-9339031879f2 | PubMed:24341474
  • Berth-Jones, J., Pollock, I., Hearn, R. M. R., Lewis-Jones, S., Goodfield, M., Griffiths, C. E. M., ... Edwards, A. M. (2014). A randomised, controlled trial of a 4% cutaneous emulsion of sodium cromoglicate in treatment of atopic dermatitis in children.The Journal of dermatological treatment, 26(3). DOI:10.3109/09546634.2014.946380
    . Publication link: 311c3b66-4676-475a-95bd-6025484fffe3 | PubMed:25034003
  • Bundy, C., Chiang, Y. Z., Griffiths, C. E. M., Paus, R., Harries, M. J., Z, C. Y., ... J, H. M. (2014). The role of beliefs: Lessons from a pilot study on illness perception, psychological distress, and quality of life in patients with primary cicatricial alopecia. British Journal of Dermatology, 172(1). DOI:10.1111/bjd.13259
    . Publication link: b4f105b8-985a-40ed-96e3-c83823bb4f01 | PubMed:25039441
  • Chularojanamontri, L., Griffiths, C. E. M., & Chalmers, R. J. G. (2014). Responsiveness to change and interpretability of the simplified psoriasis index. Journal of Investigative Dermatology, 134(2), 351-358. DOI:10.1038/jid.2013.318
    . Publication link: 3eeccc37-2351-4a36-9423-310ea3f214df | PubMed:23897275
  • Dinsdale, G., Murray, A., Moore, T., Ferguson, J., Wilkinson, J., Richards, H., ... Herrick, A. L. (2014). A comparison of intense pulsed light and laser treatment of telangiectases in patients with systemic sclerosis: a within-subject randomized trial.Rheumatology, 53(8), 1422-1430. [keu006]. DOI:10.1093/rheumatology/keu006
    . Publication link: 1be84dcd-7d52-4800-a0b1-0b5e2d310aca | PubMed:24625502
  • Eaton, L. H., Chularojanamontri, L., Ali, F. R., Theodorakopoulou, E., Dearman, R. J., Kimber, I., & Griffiths, C. E. M. (2014). Guttate psoriasis is associated with an intermediate phenotype of impaired Langerhans cell migration. British Journal of Dermatology. DOI:10.1111/bjd.12960
    . Publication link: 7460d695-5814-409b-af5c-55215101e45c | PubMed:24628096
  • Fordham, B., Griffiths, C. E. M., & Bundy, C. (2014). A pilot study examining mindfulness-based cognitive therapy in psoriasis. Psychology, Health and Medicine. DOI:10.1080/13548506.2014.902483
    . Publication link: 4786154a-0172-44bc-a081-032407e3552c | PubMed:24684520
  • Foulkes, A. C., Griffiths, C. E. M., Chinoy, H., & Warren, R. B. (2014). Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis. Journal of Dermatological Treatment, 25(1), 61-62. DOI:10.3109/09546634.2012.713460
    . Publication link: b6cb52c6-e661-4817-972d-683f38350f39 | PubMed:22812533
  • Griffiths, C. E. M., Sterry, W., Brock, F., Dilleen, M., Stefanidis, D., Germain, J. M., & Mallbris, L. (2014). Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept.The British journal of dermatology, 172(1). DOI:10.1111/bjd.13139
    . Publication link: 76d59946-7f3b-43b2-b6ef-5d7fc554ff19 | PubMed:24861696
  • Gyulai, R., Bagot, M., Griffiths, C. E. M., Luger, T., Naldi, L., Paul, C., ... Kemény, L. (2014). Current practice of methotrexate use for psoriasis: Results of a worldwide survey among dermatologists. Journal of the European Academy of Dermatology and Venereology. DOI:10.1111/jdv.12495
    . Publication link: c2adb458-c0b3-4980-b3c4-dac76962c914 | PubMed:24731093
  • Hamilton, M. P., Ntais, D., Griffiths, C. E. M., & Davies, L. M. (2014). Psoriasis treatment and management - a systematic review of full economic evaluations.The British journal of dermatology, 172(3). DOI:10.1111/bjd.13486
    . Publication link: 36790209-31d0-4248-8c8d-a1b14ab81521 | PubMed:25324036
  • Hébert, H. L., Bowes, J., Smith, R. L., McHugh, N. J., Barker, J. N. W. N., Griffiths, C. E. M., ... Warren, R. B. (2014). Polymorphisms in IL-1B distinguish between psoriasis of early and late onset. Journal of Investigative Dermatology, 134(5), 1459-1462. DOI:10.1038/jid.2013.485
    . Publication link: 30edd265-ec8e-4246-9a1a-b9df9035f039 | PubMed:24217014
  • Jani, M., Barton, A., Warren, R. B., Griffiths, C. E. M., & Chinoy, H. (2014). The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases. Rheumatology, 53(2), 213-222. [ket260]. DOI:10.1093/rheumatology/ket260
    . Publication link: 7e327757-a794-4b41-a00d-d45a8e620262 | PubMed:23946436
  • Jani, M., Massey, J., Wedderburn, L. R., Vencovský, J., Danko, K., Lundberg, I. E., ... EUMYONET, . N. V. (2014). Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies. Annals of the Rheumatic Diseases, 73(9), 1750-1752. DOI:10.1136/annrheumdis-2014-205440
    . Publication link: a39936a3-937f-423f-8adf-fe5bb9ae28dc | PubMed:24812289
  • Keyworth, C., Nelson, P. A., Chisholm, A., Griffiths, C. E. M., Cordingley, L., & Bundy, C. (2014). Providing lifestyle behaviour change support for patients with psoriasis: An assessment of the existing training competencies across medical and nursing health professionals. British Journal of Dermatology, 171(3), 602-608. DOI:10.1111/bjd.13067
    . Publication link: 8acb0b72-bdf7-4f7a-a2fd-31cb8820f247 | PubMed:24749866
  • Kimber, I., Griffiths, C. E. M., Basketter, D. A., Mcfadden, J. P., & Dearman, R. J. (2014). Epicutaneous exposure to proteins and skin immune function. European Journal of Dermatology, 24(1), 10-14. DOI:10.1684/ejd.2013.2187
    . Publication link: 991c1df6-ceac-4dc2-bf0b-ee5832f3287e | PubMed:24509254
  • Lebwohl, M., Griffiths, C. E. M., Puig, L., Nakagawa, H., Sigurgeirsson, B., Salko, T., ... Sigurgeirsson, B. (2014). Secukinumab in plaque psoriasis--results of two phase 3 trials.The New England journal of medicine, 371(4), 326-338. DOI:10.1056/NEJMoa1314258
    . Publication link: 3755361f-1ed1-44e7-b39b-f2fc1f226991 | PubMed:25007392
  • Mills, S. J., Farrar, M. D., Ashcroft, G. S., Griffiths, C. E. M., Hardman, M. J., & Rhodes, L. (2014). Topical photodynamic therapy following excisional wounding of human skin increases production of transforming growth factor-β3 and matrix metalloproteinases 1 and 9, with associated improvement in dermal matrix organization. British Journal of Dermatology, 171(1), 55-62. DOI:10.1111/bjd.12843
    . Publication link: 4ab6d9d5-7646-4385-98a1-c3aa840fc8e3 | PubMed:24471979
  • Nelson, P. A., Keyworth, C., Chisholm, A., Pearce, C. J., Griffiths, C. E. M., Cordingley, L., ... Team, T. I. M. O. P-A. C. (2014). ‘In someone's clinic but not in mine’ – clinicians’ views of supporting lifestyle behaviour change in patients with psoriasis: a qualitative interview study.British Journal of Dermatology, 171(5), 1116-1122. DOI:10.1111/bjd.13231
    . Publication link: b0fa7f4b-4f32-4a8a-9c01-fa6ddc3368fe | PubMed:24981809
  • Setta-Kaffetzi, N., Simpson, M. A., Navarini, A. A., Patel, V. M., Lu, H. C., Allen, M. H., ... Capon, F. (2014). AP1S3 mutations are associated with pustular psoriasis and impaired toll-like receptor 3 trafficking. American Journal of Human Genetics, 94(5), 790-797. DOI:10.1016/j.ajhg.2014.04.005
    . Publication link: 92949f18-aeae-4c0d-828f-19c0dea7013d | PubMed:24791904
  • Shaw, F. L., Mellody, K. T., Ogden, S., Dearman, R. J., Kimber, I., & Griffiths, C. E. M. (2014). Treatment-related restoration of langerhans cell migration in psoriasis. Journal of Investigative Dermatology, 134(1), 268-271. DOI:10.1038/jid.2013.289
    . Publication link: 2555dc67-949e-4629-aaf3-ff1d8111c6ba | PubMed:23812303
  • Tran, C., Michelet, J. F., Simonetti, L., Fiat, F., Garrigues, A., Potter, A., ... De, L. O. (2014). In vitro and in vivo studies with tetra-hydro-jasmonic acid (LR2412) reveal its potential to correct signs of skin ageing. Journal of the European Academy of Dermatology and Venereology, 28(4), 415-423. DOI:10.1111/jdv.12113
    . Publication link: e20c611b-4805-4399-8ad7-4e6fae1792bf | PubMed:23701744
  • Watson, R. E. B., Bradley, E. J., Griffiths, C. E. M., Sherratt, M. J., Bell, M., Bradley, E. J., ... Sherratt, M. J. (2014). Over-the-counter anti-ageing topical agents and their ability to protect and repair photoaged skin. Maturitas, 80(3). DOI:10.1016/j.maturitas.2014.12.019
    . Publication link: c72b8cf8-e37a-42db-88a9-b7b87f0c14f5 | PubMed:25616779
  • Watson, R. E. B., Gibbs, N. K., Griffiths, C. E. M., & Sherratt, M. J. (2014). Damage to skin extracellular matrix induced by UV exposure. Antioxidants and Redox Signaling, 21(7), 1063-1077. DOI:10.1089/ars.2013.5653
    . Publication link: 7c2ebcdb-33c1-42ce-b43c-ddbf00180d60 | PubMed:24124905
  • Watson, R. E. B., Langton, A. K., Sherratt, M. J., Sellers, W., & Griffiths, C. E. M. (2014). Geographic ancestry is a key determinant of epidermal morphology and dermal composition. British Journal of Dermatology. DOI:10.1111/bjd.12860
    . Publication link: 093f40fc-3c23-4ae9-a932-ce62ecbf1d1c | PubMed:24484315
  • Yiu, Z. Z. N., Griffiths, C. E. M., & Warren, R. B. (2014). Safety of biological therapies for psoriasis: Effects on reproductive potential and outcomes in male and female patients. British Journal of Dermatology, 171(3). DOI:10.1111/bjd.13060
    . Publication link: 6a48c028-d3cf-4822-ba8b-9b4836c24f44 | PubMed:24749725

2013

  • Ali, F. R., Barton, A., Smith, R. L. I., Bowes, J., Flynn, E., Mangino, M., ... Warren, R. B. (2013). An investigation of rheumatoid arthritis loci in patients with early-onset psoriasis validates association of the REL gene.The British journal of dermatology, 168(4), 864-866. DOI:10.1111/bjd.12106
    . Publication link: c09c128d-5920-4888-bc10-3ab10135b541 | PubMed:23106574
  • Bundy, C., Pinder, B., Bucci, S., Reeves, D., Griffiths, C. E. M., & Tarrier, N. (2013). A novel, web-based, psychological intervention for people with psoriasis: The electronic Targeted Intervention for Psoriasis (eTIPs) study. British Journal of Dermatology, 169(2), 329-336. DOI:10.1111/bjd.12350
    . Publication link: e5b772bf-a4ef-4dd6-a977-32cd15994306 | PubMed:23551271
  • Chularojanamontri, L., & Griffiths, C. E. M. (2013). Biologic therapies in dermatology. British Journal of Hospital Medicine, 74(1), 12-17.
    . Publication link: cd75adac-a0a8-420e-90ea-b27a8e97a385 | PubMed:23593668
  • Chularojanamontri, L., Griffiths, C. E. M., & Chalmers, R. J. G. (2013). The simplified psoriasis index (SPI): A practical tool for assessing psoriasis. Journal of Investigative Dermatology, 133(8), 1956-1962. DOI:10.1038/jid.2013.138
    . Publication link: f9b0613f-93b9-48a7-8b24-7dae1cfa3e76 | PubMed:23807685
  • Ennis, H., Herrick, A. L., Cassidy, C., Griffiths, C. E. M., & Richards, H. L. (2013). A pilot study of body image dissatisfaction and the psychological impact of systemic sclerosis-related telangiectases. Clinical and Experimental Rheumatology, 31(76), S12-S17.
    . Publication link: cf42ae8a-c7a8-4509-9133-685712f8af34 | PubMed:23324653
  • Ennis, H., Vail, A., Wragg, E., Taylor, A., Moore, T., Murray, A., ... Herrick, A. L. (2013). A prospective study of systemic sclerosis-related digital ulcers: Prevalence, location, and functional impact. Scandinavian Journal of Rheumatology, 42(6), 483-486. DOI:10.3109/03009742.2013.780095
    . Publication link: 44dbba71-68c9-4c3d-87ad-13f50a51b4c2 | PubMed:23826651
  • Fordham, B., Griffiths, C. E. M., & Bundy, C. (2013). Can stress reduction interventions improve psoriasis? A review. Psychology, Health and Medicine, 18(5), 501-514. DOI:10.1080/13548506.2012.736625
    . Publication link: 5372178e-7959-4219-82c4-c94db4713a49 | PubMed:23116223
  • Gunn, D. A., De Craen, A. J. M., Dick, J. L., Tomlin, C. C., Van Heemst, D., Catt, S. D., ... Kritchevsky, S. (2013). Facial appearance reflects human familial longevity and cardiovascular disease risk in healthy individuals. Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 68(2), 145-152. DOI:10.1093/gerona/gls154
    . Publication link: 76ac21d1-92bf-449a-b63e-7aaea73530db | PubMed:22879455
  • Harries, M. J., Meyer, K., Chaudhry, I., E Kloepper, J., Poblet, E., Griffiths, C. E. M., & Paus, R. (2013). Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche. Journal of Pathology, 231(2), 236-247. DOI:10.1002/path.4233
    . Publication link: 3490f078-b943-4aa4-85b4-75bafcc92c8d | PubMed:23788005
  • Hunter, H. J. A., Griffiths, C. E. M., & Kleyn, C. E. (2013). Does psychosocial stress play a role in the exacerbation of psoriasis?. British Journal of Dermatology, 169(5), 965-974. DOI:10.1111/bjd.12478
    . Publication link: de939728-45b3-4142-adf3-1c403149efa3 | PubMed:23796214
  • Langan, E. A., Lisztes, E., Bíro, T., Funk, W., Kloepper, J. E., Griffiths, C. E. M., & Paus, R. (2013). Dopamine is a novel, direct inducer of catagen in human scalp hair follicles in vitro. British Journal of Dermatology, 168(3), 520-525. DOI:10.1111/bjd.12113
    . Publication link: a5cd7f75-fae6-408e-8715-36056771216b | PubMed:23176199
  • Langan, E. A., Vidali, S., Pigat, N., Funk, W., Lisztes, E., Bíró, T., ... Paus, R. (2013). Tumour Necrosis Factor Alpha, Interferon Gamma and Substance P Are Novel Modulators of Extrapituitary Prolactin Expression in Human Skin. PLoS ONE, 8(4), [e60819]. DOI:10.1371/journal.pone.0060819
    . Publication link: 4a1ccc0f-7879-43f4-912e-3992a75f859a | PubMed:23626671
  • Langton, A. K., Griffiths, C. E. M., Sherratt, M. J., & Watson, R. E. B. (2013). Cross-linking of structural proteins in ageing skin: An in situ assay for the detection of amine oxidase activity. Biogerontology, 14(1), 89-97. DOI:10.1007/s10522-012-9394-3
    . Publication link: 6bb643b9-1705-4d2a-8462-a704799e05d1 | PubMed:22923173
  • Mrowietz, U., Kragballe, K., Reich, K., Griffiths, C. E. M., Gu, Y., Wang, Y., & Rozzo, S. J. (2013). An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals. British Journal of Dermatology, 168(2), 374-380. DOI:10.1111/j.1365-2133.2012.11214.x
    . Publication link: eb037997-5496-488b-9313-c3e3fb8d1d43 | PubMed:22880843
  • Nelson, P. A., Barker, Z., Griffiths, C. E., Cordingley, L., Chew-Graham, C. A., & Lovell, K. (2013). 'On the surface': A qualitative study of GPs' and patients' perspectives on psoriasis. BMC family practice, 14, [158]. DOI:10.1186/1471-2296-14-158
    . Publication link: 30e70d7a-d635-4946-a664-6b59756cf103 | PubMed:24138455
  • Nelson, P. A., Chew-Graham, C. A., Griffiths, C. E. M., & Cordingley, L. (2013). Recognition of need in health care consultations: A qualitative study of people with psoriasis. British Journal of Dermatology, 168(2), 354-361. DOI:10.1111/j.1365-2133.2012.11217.x
    . Publication link: 9826e9da-4050-40a0-83bb-8264db945511 | PubMed:22880951
  • Noordam, R., Gunn, D. A., Tomlin, C. C., Maier, A. B., Griffiths, T., Catt, S. D., ... De Craen, A. J. M. (2013). Serum insulin-like growth factor 1 and facial ageing: High levels associate with reduced skin wrinkling in a cross-sectional study. British Journal of Dermatology, 168(3), 533-538. DOI:10.1111/bjd.12131
    . Publication link: 99a4a808-6183-4e9d-8a26-886523683cb3 | PubMed:23363376
  • Papp, K. A., Griffiths, C. E. M., Gordon, K., Lebwohl, M., Szapary, P. O., Wasfi, Y., ... Reich, K. (2013). Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: Final results from 5 years of follow-up. British Journal of Dermatology, 168(4), 844-854. DOI:10.1111/bjd.12214
    . Publication link: 0c871e2c-656d-46db-b895-77305d7c8948 | PubMed:23301632
  • Parisi, R., Symmons, D. P. M., Griffiths, C. E. M., & Ashcroft, D. M. (2013). Global epidemiology of psoriasis: A systematic review of incidence and prevalence. Journal of Investigative Dermatology, 133(2), 377-385. DOI:10.1038/jid.2012.339
    . Publication link: b2819fb5-b46f-4a64-a274-36bd289beca9 | PubMed:23014338
  • Roberts, J. C., Warren, R. B., Griffiths, C. E. M., & Ross, K. (2013). Expression of microRNA-184 in keratinocytes represses argonaute 2. Journal of Cellular Physiology, 228(12), 2314-2323. DOI:10.1002/jcp.24401
    . Publication link: 6f8a3515-96fe-44fd-b611-8108ef188653 | PubMed:23696368
  • Sathish, J. G., Sethu, S., Bielsky, M. C., De Haan, L., French, N. S., Govindappa, K., ... Park, B. K. (2013). Challenges and approaches for the development of safer immunomodulatory biologics. Nature Reviews Drug Discovery, 12(4), 306-324. DOI:10.1038/nrd3974
    . Publication link: d438ec7a-be80-4e34-8185-9f6c6dd30ed4 | PubMed:23535934
  • Thorneloe, R. J., Bundy, C., Griffiths, C. E. M., Ashcroft, D. M., & Cordingley, L. (2013). Adherence to medication in patients with psoriasis: A systematic literature review. British Journal of Dermatology, 168(1), 20-31. DOI:10.1111/bjd.12039
    . Publication link: d690acb8-6582-4014-80d2-71b317c77936 | PubMed:22963128

2012

2011

  • Bowes, J., Eyre, S., Flynn, E., Ho, P., Salah, S., Warren, R. B., ... Barton, A. (2011). Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Annals of the Rheumatic Diseases, 70(6), 1016-1019. DOI:10.1136/ard.2010.143123
    . Publication link: e3f10b93-c0ce-4b38-b5dd-fbb75b0718d6 | PubMed:21349879
  • Chiang, Y. Z., Tan, K. T., Chiang, Y. N., Burge, S. M., Griffiths, C. E. M., & Verbov, J. L. (2011). Evaluation of educational methods in dermatology and confidence levels: A national survey of UK medical students. International Journal of Dermatology, 50(2), 198-202. DOI:10.1111/j.1365-4632.2010.04664.x
    . Publication link: 21368405-bd3a-4f21-8212-0c804467e9d3 | PubMed:21244386
  • Foulkes, A. C., Grindlay, D. J. C., Griffiths, C. E. M., & Warren, R. B. (2011). What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010. Clinical and Experimental Dermatology, 36(6), 585-588. DOI:10.1111/j.1365-2230.2011.04108.x
    . Publication link: f61b0d63-888b-42f7-ae37-ca28f88a19f7 | PubMed:21718345
  • Kerkhof, P. V. D., Barker, J., Griffiths, C. E. M., Menter, A., Leonardi, C., Young, M., ... Sterry, W. (2011). Improving clinical trial design in psoriasis: Perspectives from the global dermatology community. Journal of Dermatological Treatment, 22(4), 187-193. DOI:10.3109/09546634.2010.487888
    . Publication link: 06bf3470-c2e0-4131-93aa-c999be31152b | PubMed:20887207
  • Langan, E. A., Griffiths, C. E. M., & Paus, R. (2011). In search of the source of hyperprolactinaemia in systemic lupus erythematosus. Clinical and Experimental Rheumatology, 29(6), 1060.
    . Publication link: 36aecaa4-e5b1-45cb-9ab7-886ac796f56e | PubMed:22032729
  • Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C. E. M., Nast, A., ... Yawalkar, N. (2011). Definition of treatment goals for moderate to severe psoriasis: A European consensus. Archives of Dermatological Research, 303(1), 1-10. DOI:10.1007/s00403-010-1080-1
    . Publication link: 9b6307d3-9623-4094-8a85-e8ec527b95cc | PubMed:20857129
  • Newman, W. G., Payne, K., Tricker, K., Roberts, S. A., Fargher, E., Pushpakom, S., ... Ollier, W. E. R. (2011). A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: The TARGET study. Pharmacogenomics, 12(6), 815-826. DOI:10.2217/pgs.11.32
    . Publication link: 123db8fa-3bbf-4420-bfe7-57001a3883d3 | PubMed:21692613
  • Ogden, S., Dearman, R. J., Kimber, I., & Griffiths, C. E. M. (2011). The effect of ageing on phenotype and function of monocyte-derived Langerhans cells. British Journal of Dermatology, 165(1), 184-188. DOI:10.1111/j.1365-2133.2011.10313.x
    . Publication link: 99b0edeb-612e-4b6b-b115-278d0da0cd48 | PubMed:21410677
  • Reich, K., Langley, R. G., Lebwohl, M., Szapary, P., Guzzo, C., Yeilding, N., ... Griffiths, C. E. M. (2011). Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: Results of integrated analyses of data from phase II and III clinical studies. British Journal of Dermatology, 164(4), 862-872. DOI:10.1111/j.1365-2133.2011.10257.x
    . Publication link: 725486f0-3522-48f2-a505-5a979ef514bf | PubMed:21332467
  • Warren, R. B., Smith, R. L., Flynn, E., Bowes, J., Eyre, S., Worthington, J., ... Griffiths, C. E. M. (2011). A systematic investigation of confirmed autoimmune loci in early-onset psoriasis reveals an association with IL2/IL21. British Journal of Dermatology, 164(3), 660-664. DOI:10.1111/j.1365-2133.2011.10237.x
    . Publication link: 82982206-6455-40cb-a2eb-0a17743a2431 | PubMed:21375519
  • Farrar, M. D., Mills, S. J., Griffiths, C., Ashcroft, G. S., & Rhodes, L. (2011). Photodynamic therapy modulates inflammation and positively influences healing of excisional wounds in human skin. In Oral presentation.
    . Publication link: 8e5635fe-999d-4baf-ae15-4c74b9e36339
  • Farrar, M. D., Mills, S. J., Griffiths, C., Ashcroft, G. S., & Rhodes, L. (2011). Photodynamic therapy modulates production of TGF-b1 in association with improved healing in excisional wounds of human skin. In Oral presentation.
    . Publication link: 421b1da0-8448-417f-95d6-15dc38ee434d

2010

2009

2008

  • Capon, F., Bijlmakers, M. J., Wolf, N., Quaranta, M., Huffmeier, U., Allen, M., ... Trembath, R. C. (2008). Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene. Human Molecular Genetics, 17(13), 1938-1945. DOI:10.1093/hmg/ddn091
    . Publication link: 2bd1cdba-d633-4a0d-8a8b-19f3461eb621 | PubMed:18364390
  • El-Rachkidy, R. G., Young, H. S., Griffiths, C. E. M., & Camp, R. D. R. (2008). Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis. Journal of Investigative Dermatology, 128(9), 2219-2224. DOI:10.1038/jid.2008.71
    . Publication link: 586627e7-5d58-496a-8beb-ead1a12c6eac
  • Griffiths, C. E. M., & Reich, K. (2008). The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab.Arch Dermatol Res, 300( 10). DOI:10.1007/s00403-008-0885-7
    . Publication link: 4d1fb3c6-63ec-4a04-b1a0-430e29f8a581
  • Harries, M. J., Sinclair, R. D., MacDonald-Hull, S., Whiting, D. A., Griffiths, C. E. M., & Paus, R. (2008). Management of primary cicatricial alopecias: Options for treatment. British Journal of Dermatology, 159(1), 1-22. DOI:10.1111/j.1365-2133.2008.08591.x
    . Publication link: c1c3d8e2-92fb-49e7-9c9a-8d5cded12139
  • Ho, P. Y. P. C., Barton, A., Worthington, J., Plant, D., Griffiths, C. E. M., Young, H. S., ... Bruce, I. N. (2008). Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: Comparison with psoriasis and undifferentiated inflammatory arthritis. Annals of the Rheumatic Diseases, 67(5), 677-682. DOI:10.1136/ard.2007.071399
    . Publication link: b0785510-9c5f-4e3f-82fa-791a0dc940cd
  • Hussain, W., Ogden, S., Lavery, D., & Griffiths, C. E. M. (2008). Making a 'point' about the safe disposal of sharps in patients on biological therapies. British Journal of Dermatology, 159(2), 491-492. DOI:10.1111/j.1365-2133.2008.08639.x
    . Publication link: a8ebfd73-6ba3-431b-ab98-a5afddcb7b96
  • Kirby, B., Richards, H. L., Mason, D. L., Fortune, D. G., Main, C. J., & Griffiths, C. E. M. (2008). Alcohol consumption and psychological distress in patients with psoriasis. British Journal of Dermatology, 158(1), 138-140. DOI:10.1111/j.1365-2133.2007.08299.x
    . Publication link: 4a1295c1-a281-4696-a13b-8178fab3a06b
  • Ogden, S., & Griffiths, C. E. M. (2008). Viewpoint 2. Experimental Dermatology, 17(3), 230-231. DOI:10.1111/j.1600-0625.2007.00665_2.x
    . Publication link: 4a406852-e95f-46fa-ba84-66915fda6ff5
  • Ogden, S., Samuel, M., & Griffiths, C. E. M. (2008). A review of tazarotene in the treatment of photodamaged skin. Clinical Interventions in Aging, 3(1), 71-76. DOI:10.2147/CIA.S1101
    . Publication link: 219be9d8-cf8e-43fb-b461-8d7f8b2d0378
  • Reich, K., Sinclair, R., Roberts, G., Griffiths, C. E. M., Tabberer, M., & Barker, J. (2008). Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: A meta-analysis. Current Medical Research and Opinion, 24(5), 1237-1254. DOI:10.1185/030079908X291985
    . Publication link: 869d8e38-8821-494f-8804-a928be2da543
  • Rich, P., Griffiths, C. E. M., Reich, K., Nestle, F. O., Scher, R. K., Li, S., ... Guzzo, C. (2008). Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. Journal of the American Academy of Dermatology, 58(2), 224-231. DOI:10.1016/j.jaad.2007.07.042
    . Publication link: 6380b1a0-6713-4207-96e4-69e23fc39f8a
  • Richards, H. L., Fortune, D. G., & Griffiths, C. E. M. (2008). The Greater Patient concept [4]. British Journal of Dermatology, 158(1), 176-178. DOI:10.1111/j.1365-2133.2007.08247.x
    . Publication link: 12b41e9b-1d2d-4e31-b036-78bdacdc2db5
  • Skvara, H., Dawid, M., Kleyn, E., Wolff, B., Meingassner, J. G., Knight, H., ... Jung, T. (2008). The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. Journal of Clinical Investigation, 118(9), 3151-3159. DOI:10.1172/JCI35636
    . Publication link: 1ddff731-22d2-4773-ae81-15d412f7cc92
  • Van De Kerkhof, P. C. M., Barker, J., Griffiths, C. E. M., Kragballe, K., Mason, J., Menter, A., & Papp, K. (2008). Psoriasis: Consensus on topical therapies. Journal of the European Academy of Dermatology and Venereology, 22(7), 859-870. DOI:10.1111/j.1468-3083.2007.02534.x
    . Publication link: cc3f37c0-9301-4e22-98c6-239e73190bde
  • Warren, R. B., & Griffiths, C. E. M. (2008). Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. Clinics in Dermatology, 26(5), 438-447. DOI:10.1016/j.clindermatol.2007.11.006
    . Publication link: 0d9b0552-b119-4080-b2f9-1a5ad950affd
  • Warren, R. B., Brown, B. C., & Griffiths, C. E. M. (2008). Topical treatments for scalp psoriasis. Drugs, 68(16), 2293-2302. DOI:10.2165/0003495-200868160-00003
    . Publication link: a81e1633-3d22-4d0e-b12c-3dc071f4bf6b | PubMed:18973394
  • Warren, R., Smith, R. L., Eyre, S., Warren, R. B., Young, H. S., Griffiths, C. E. M., & Worthington, J. (2008). No association between polymorphisms in the interleukin-15 gene and early-onset psoriasis in a UK cohort suggests heterogeneity for this susceptibility locus identified in Chinese psoriasis patients. Journal of Investigative Dermatology, 128(12), 2904-2905. DOI:10.1038/jid.2008.148
    . Publication link: 1665e690-a4e8-4191-abf2-ea99d2ee7444
  • Warren, R., Smith, R. L., Warren, R. B., Eyre, S., Ho, P., Ke, X., ... Worthington, J. (2008). Polymorphisms in the IL-12β and IL-23R genes are associated with psoriasis of early onset in a UK cohort. Journal of Investigative Dermatology, 128(5), 1325-1327. DOI:10.1038/sj.jid.5701140
    . Publication link: 1c3964a8-ce70-4dd1-aebe-4b4081bb1718
  • Warren, R., Smith, R. L., Warren, R. B., Eyre, S., Ke, X., Young, H. S., ... Worthington, J. (2008). Polymorphisms in the PTPN22 region are associated with psoriasis of early onset. British Journal of Dermatology, 158(5), 962-968. DOI:10.1111/j.1365-2133.2008.08482.x
    . Publication link: 8a1aff29-4ab1-45a6-b412-80cb175c9d43 | PubMed:18341666
  • Warren, R., Warren, R. B., Chalmers, R. J. G., Griffiths, C. E. M., & Menter, A. (2008). Methotrexate for psoriasis in the era of biological therapy. Clinical and Experimental Dermatology, 33(5), 551-554. DOI:10.1111/j.1365-2230.2008.02976.x
    . Publication link: 9e4bd314-c0a0-487f-a3fb-949e4c1cb114 | PubMed:18801095
  • Warren, R., Warren, R. B., Smith, R. L., Campalani, E., Eyre, S., Smith, C. H., ... Griffiths, C. E. M. (2008). Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis. Journal of Investigative Dermatology, 128(8), 1925-1929. DOI:10.1038/jid.2008.16
    . Publication link: 2f165848-24ef-40a0-8351-7b95af6ec56c | PubMed:18256692
  • Watson, R. E. B., Long, S. P., Bowden, J. J., Bastrilles, J. Y., Barton, S. P., & Griffiths, C. E. M. (2008). Repair of photoaged dermal matrix by topical application of a cosmetic 'antiageing' product. British Journal of Dermatology, 158(3), 472-477. DOI:10.1111/j.1365-2133.2007.08364.x
    . Publication link: 2b3a84e0-9bfb-4fe0-af14-3e9beecb9b62
  • Wolf, N., Quaranta, M., Prescott, N. J., Allen, M., Smith, R., Burden, A. D., ... Trembath, R. C. (2008). Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. Journal of Medical Genetics, 45(2), 114-116. DOI:10.1136/jmg.2007.053595
    . Publication link: cd0bafd2-80ca-4cd1-a2e1-6db2515c18ba
  • Woods, A. L., Rutter, K. J., Gardner, L. S., Lewis, V. J., Saxena, S., George, S. A., ... Smith, C. H. (2008). Inpatient management of psoriasis: A multicentre service review to establish national admission standards. British Journal of Dermatology, 158(2), 266-272. DOI:10.1111/j.1365-2133.2007.08338.x
    . Publication link: 9572a69f-8bce-480e-82d0-675d0ae2224e
  • Ho, P. Y. P. C., Barton, A., Worthington, J., Plant, D., Griffiths, C. E. M., Young, H. S., ... Bruce, I. N. (2008). Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: Comparison with psoriasis and undifferentiated inflammatory arthritis. (Ann Rheum Dis; Vol. 67( 5)). England: Academic Press. DOI:10.1136/ard.2007.071399
    . Publication link: 13250992-ca9b-4082-b4fd-37e58b7565c6
  • Ke, X., Griffiths, C. E. M., Eyre, S. S., Worthington, J., Smith, R., Warren, R. B., ... Young, H. (2008). Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort.J Invest Dermatol, 128( 5).
    . Publication link: bd030c78-dd7f-4115-9850-fc78e550dc46

2007

2006

  • Ashcroft, D. M., Seston, E., & Griffiths, C. E. M. (2006). Trade-offs between the benefits and risks of drug treatment for psoriasis: A discrete choice experiment with U.K. dermatologists. British Journal of Dermatology, 155(6), 1236-1241. DOI:10.1111/j.1365-2133.2006.07535.x
    . Publication link: 793ded63-2801-4758-b401-ecc52fa4f8d4
  • Atwal, G. S. S., Manku, L. K., Griffiths, C. E. M., & Polson, D. W. (2006). Striae gravidarum in primiparae. British Journal of Dermatology, 155(5), 965-969. DOI:10.1111/j.1365-2133.2006.07427.x
    . Publication link: 55b25d22-5ac4-4375-861a-7b2606800018
  • Brooklyn, T. N., Dunnill, M. G. S., Shetty, A., Bowden, J. J., Williams, J. D. L., Griffiths, C. E. M., ... Probert, C. S. (2006). Infliximab for the treatment of pyoderma gangrenosum: A randomised, double blind, placebo controlled trial. Gut, 55(4), 505-509. DOI:10.1136/gut.2005.074815
    . Publication link: 907e9970-dbc6-4537-ad15-84cc694a8ed2
  • Campalani, E., Allen, M. H., Fairhurst, D., Young, H. S., Mendonca, C. O., Burden, A. D., ... Smith, C. H. (2006). Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. British Journal of Dermatology, 154(2), 345-352. DOI:10.1111/j.1365-2133.2005.06950.x
    . Publication link: 121a0bfb-18bd-4be5-ac19-1e1bf1544996
  • Christophers, E., Griffiths, C. E. M., Gaitanis, G., & Van De Kerkhof, P. (2006). The unmet treatment need for moderate to severe psoriasis: Results of a survey and chart review. Journal of the European Academy of Dermatology and Venereology, 20(8), 921-925. DOI:10.1111/j.1468-3083.2006.01667.x
    . Publication link: 490f1f8c-9c27-46ad-afaf-a3b7c31effc1
  • Cumberbatch, M., Singh, M., Dearman, R. J., Young, H. S., Kimber, I., & Griffiths, C. E. M. (2006). Impaired Langerhans cell migration in psoriasis. Journal of Experimental Medicine, 203(4), 953-960. DOI:10.1084/jem.20052367
    . Publication link: 8dfb07a4-b70b-4a20-a554-9366287468e1 | PubMed:16567387
  • Griffiths, C. E. M., Clements, S. E., & Abdul-Ghaffer, S. (2006). Biological therapy for psoriasis. Br J of Hospital Medicine, 67.
    . Publication link: 34061e7b-4c13-4b6b-a20f-5732f7a0784c
  • Griffiths, C. E. M., Finlay, A. Y., Fleming, C. J., Barker, J. N. W. N., Mizzi, F., & Arsonnaud, S. (2006). A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis. Journal of Dermatological Treatment, 17(2), 90-95. DOI:10.1080/09546630500515701
    . Publication link: 2ce68313-c0a7-49cf-af35-8a019d409363
  • Griffiths, C. E. M., Iaccarino, L., Naldi, L., Olivieri, I., Pipitone, N., Salvarani, C., & Doria, A. (2006). Psoriasis and psoriatic arthritis: Immunological aspects and therapeutic guidelines. Clinical and Experimental Rheumatology, 24(40), S72-S78.
    . Publication link: 9843ecc4-99b3-4533-8470-48889782239c
  • Griffiths, C. E. M., Katsambas, A., Dijkmans, B. A. C., Finlay, A. Y., Ho, V. C., Johnston, A., ... Thestrup-Pedersen, K. (2006). Update on the use of ciclosporin in immune-mediated dermatoses. British Journal of Dermatology, 155(2), 1-16. DOI:10.1111/j.1365-2133.2006.07343.x
    . Publication link: c9876592-8db6-47ff-ae17-2d2e4a45ff74
  • Harries, M. J., McMullen, E., & Griffiths, C. E. M. (2006). Pyoderma gangrenosum masquerading as dermatitis artefacta [4]. Archives of Dermatology, 142(11), 1509-1510.
    . Publication link: f8aefd22-3e36-485f-9c49-ab0bc3e14cfa
  • Kleyn, C. E., & Griffiths, C. E. M. (2006). Infliximab for the treatment of psoriasis. Expert Opinion on Biological Therapy, 6(8), 797-805. DOI:10.1517/14712598.6.8.797
    . Publication link: f4ec18a9-e954-470b-8f64-76a0772edde9
  • Macdonald, N., Cumberbatch, M., Singh, M., Moggs, J. G., Orphanides, G., Dearman, R. J., ... Kimber, I. (2006). Proteomic analysis of suction blister fluid isolated from human skin. Clinical and Experimental Dermatology, 31(3), 445-448. DOI:10.1111/j.1365-2230.2006.02078.x
    . Publication link: 418ad59f-8ecb-4dc2-96c0-b49217d5d852 | PubMed:16681597
  • Mendonça, C. O., & Griffiths, C. E. M. (2006). Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. British Journal of Dermatology, 154(5), 977-978. DOI:10.1111/j.1365-2133.2006.07155.x
    . Publication link: d136166b-4e90-4629-881d-3b47521fb239
  • Plant, D., Young, H. S., Watson, R. E. B., Worthington, J., & Griffiths, C. E. M. (2006). The CX3CL1-CX3CR1 system and psoriasis. Experimental Dermatology, 15(11), 900-903. DOI:10.1111/j.1600-0625.2006.00486.x
    . Publication link: ba241147-208d-4bf3-a9d9-8aee4afbd9f6
  • Reich, K., Nestle, F. O., Papp, K., Ortonne, J. P., Wu, Y., Bala, M., ... Griffiths, C. E. M. (2006). Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: A randomized controlled trial. British Journal of Dermatology, 154(6), 1161-1168. DOI:10.1111/j.1365-2133.2006.07237.x
    . Publication link: 869b7db7-f35a-4fd9-954b-96c8902c142e
  • Saraceno, R., & Griffiths, C. E. M. (2006). A European perspective on the challenges of managing psoriasis. Journal of the American Academy of Dermatology, 54(3), S81-S84. DOI:10.1016/j.jaad.2005.10.051
    . Publication link: 84199f4d-826d-456a-973f-1c9d6d076569
  • Saraceno, R., Kleyn, C. E., Terenghi, G., & Griffiths, C. E. M. (2006). The role of neuropeptides in psoriasis. British Journal of Dermatology, 155(5), 876-882. DOI:10.1111/j.1365-2133.2006.07518.x
    . Publication link: 02bda221-86bb-4189-b80b-3712633ba53a
  • Singh, M., & Griffiths, C. E. M. (2006). The use of retinoids in the treatment of photoaging. Dermatologic Therapy, 19(5), 297-305. DOI:10.1111/j.1529-8019.2006.00087.x
    . Publication link: caea1a9b-5c51-4d5d-bd5c-de0c2b566223
  • Tsoureli-Nikita, E., Watson, R. E. B., & Griffiths, C. E. M. (2006). Photoageing: The darker side of the sun. Photochemical and Photobiological Sciences, 5(2), 160-164. DOI:10.1039/b507492d
    . Publication link: 136e2eb6-e2d8-427f-a3da-68af5e787e0a
  • Warren, R. B., & Griffiths, C. E. M. (2006). Anti-TNF drugs in dermatology and inflammatory bowel disease - Where are we going?. Future Prescriber Article, 7.
    . Publication link: 3acd49bc-7d10-4217-aa2b-aa561e055a1b
  • Warren, R. B., Griffiths, C. E. M., Stewart, L., & Roberts, A. (2006). Using biological therapies for psoriasis and other inflammatory dermatoses. Dermatology in Practice, 14.
    . Publication link: b173db22-1f1c-46e2-b3f8-94d9ecba2066
  • Young, H., Young, H. S., Summers, A. M., Read, I. R., Fairhurst, D. A., Plant, D. J., ... Griffiths, C. E. M. (2006). Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. Journal of Investigative Dermatology, 126(2), 453-459. DOI:10.1038/sj.jid.5700096
    . Publication link: e200f59f-efe9-4cc6-bb8e-701c55e0093a
  • Brownrigg, M., Griffiths, C. E. M., Rutter, K., Cotterell, L. F., Watson, R. E. B., Chalmers, R. J. G., & Rhodes, L. E. (2006). Clinical and photobiological characteristics of patients with photosensitive psoriasis.In British Journal Of Dermatology. (Vol. 155S). Academic Press.
    . Publication link: 34abc966-1719-4229-9ed1-1b88b95c0e4c
  • Griffiths, C. E. M., Watson, R. E. B., Cotterell, L. F., Rutter, K., Brenn, T., Chalmers, R. J. G., & Rhodes, L. E. (2006). Low dose UVB challenge causes early histological abnormalities in uninvolved skin of patients with photosensitive psoriasis.In British Journal Of Dermatology. (Vol. 155). Academic Press.
    . Publication link: 5ada1071-3717-4a02-a5ed-492a5727ad82
  • Griffiths, C. E. M., Watson, R. E. B., Cotterell, L. F., Rutter, K., Brenn, T., Chalmers, R. J. G., & Rhodes, L. E. (2006). Role of memory effector T lymphocytes in the early phase of photosensitive psoriasis.In Journal Of Investigative Dermatology. (Vol. 126S). Academic Press.
    . Publication link: b6ce70d2-e41d-413e-892c-43257cddee78

2005

  • Allen, M. H., Ameen, H., Veal, C., Evans, J., Ramrakha-Jones, V. S., Marsland, A. M., ... Barker, J. N. W. N. (2005). The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis. Journal of Investigative Dermatology, 124(1), 103-106. DOI:10.1111/j.0022-202X.2004.23511.x
    . Publication link: fe833adf-7192-478f-aa98-1950c7321eaf
  • Chan, J. J., Young, H. S., Griffiths, C. E. M., & Cather, J. (2005). Efalizumab: A viewpoint. American Journal of Clinical Dermatology, 6(2), 119-120.
    . Publication link: 8522168c-9811-436f-87e5-f1a71a6b6a04
  • Fairhurst, D. A., Ashcroft, D. M., & Griffiths, C. E. M. (2005). Optimal management of severe plaque form of psoriasis. American Journal of Clinical Dermatology, 6(5), 283-294. DOI:10.2165/00128071-200506050-00002
    . Publication link: 96359a70-8952-43e8-9d52-84ff3463afd7
  • Fargher, E. A., Tricker, K., Newman, W. G., Qasim, F. F., Andrews, J., Elliott, R. A., ... Olier, W. E. R. (2005). Research Governance: What is reasonable protection?. BMJ Rapid Response.
    . Publication link: 7c3dab8e-b45a-40d1-83bc-d6f1622c1845
  • Ghaffar, S. A., Clements, S. E., & Griffiths, C. E. M. (2005). Modern management of psoriasis. Clinical Medicine, Journal of the Royal College of Physicians of London, 5(6), 564-568.
    . Publication link: 3167efd4-6c75-4ad9-9545-d1bdd2bfb407
  • Gottlieb, A. B., Griffiths, C. E. M., Ho, V. C., Lahfa, M., Mrowietz, U., Murrell, D. F., ... Paul, C. F. (2005). Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: A double-blind, multicentre, randomized, dose-finding trial. British Journal of Dermatology, 152(6), 1219-1227. DOI:10.1111/j.1365-2133.2005.06661.x
    . Publication link: b3671132-aa96-4933-91de-a088e02aaed2
  • Griffiths, C. E. M. (2005). Ciclosporin in psoriasis consensus statement: reply from authors. British Journal of Dermatology, 152.
    . Publication link: 209ba8bb-b611-4c6f-9b66-41f8cda021a0
  • Griffiths, C. E. M. (2005). Controversies in experimental dermatology. EXPERIMENTAL DERMATOLOGY, 14, 398-9. DOI:10.1111/j.0906-6705.2005.0323b.x
    . Publication link: 9f509791-e4e7-4f6c-a509-cb7559cfc905
  • Griffiths, C. E. M., & Watson, R. E. B. (2005). Pathogenic aspects of cutaneous photoageing. Journal of Cosmetic Dermatology, 4.
    . Publication link: e2055151-ca4d-43aa-9bc8-ef33513e63ed
  • Griffiths, C. E. M., & Winhoven, S. (2005). What GPs need to know about TNF-alpha inhibitors.Dermatology in Practice, 13.
    . Publication link: ea8ace0d-4d05-489f-8cfa-a2f64134e278
  • Griffiths, C. E. M., Dearman, R. J., Cumberbatch, M., & Kimber, I. (2005). Cytokines and Langerhans cell mobilisation in mouse and man. Cytokine, 32(2), 67-70. DOI:10.1016/j.cyto.2005.07.011
    . Publication link: 009afa1c-01f3-47d6-ad40-35cf06e58ace | PubMed:16153855
  • Griffiths, C. E. M., Grueger, G. G., Langley, R. G., Finlay, A. Y., Woolley, J. M., Lalla, D., & Jahreis, A. (2005). Patient-Reported outcomes of psoriasis improvement with Etanercept therapy: Results of a randomized phase 3 trial.British Journal of Dermatology.
    . Publication link: e40e9a91-8f1f-4f4a-baac-9a31bbedad6a
  • Griffiths, C. E. M., Krueger, G. G., Langley, R. G., Finlay, A. Y., Woolley, J. M., Lalla, D., & Jahreis, A. (2005). Interaction between Genetic Control of Vascular Endothelial Growth Factor Production and Retinoid Responsiveness in Psoriasis. Journal of Investigative dermatology, 153.
    . Publication link: 5dfeae35-b303-42d0-aa5a-ee046b04f6e6
  • Griffiths, C. E. M., Maddin, S., Wiedow, O., Marks, R., Donald, A. E., & Kahlon, G. (2005). Treatment of photoaged skin with a cream containing 0.05% isotretinoin and sunscreens. Journal of Dermatological Treatment, 16(2), 79-86. DOI:10.1080/09546630510027732
    . Publication link: 64b4dfcd-6517-4b6e-aac7-2b808736d595
  • Griffiths, C., Smith, C. H., Anstey, A. V., Barker, J. N. W. N., Burden, A. D., Chalmers, R. J. G., ... Ormerod, A. D. (2005). British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. British Journal of Dermatology, 153(3), 486-497. DOI:10.1111/j.1365-2133.2005.06893.x
    . Publication link: 362ae242-ed80-457f-a239-eb136dc22421
  • Griffiths, M. J. D., Bonnet, D., & Janes, S. M. (2005). Stem cells of the alveolar epithelium. The Lancet, 366(9481), 249-260. DOI:10.1016/S0140-6736(05)66916-4
    . Publication link: c9cb9996-82e7-4378-808c-2100d51765cb
  • Harries, M. J., Chalmers, R. J. G., & Griffiths, C. E. M. (2005). Fumaric acid esters for severe psoriasis: A retrospective review of 58 cases. British Journal of Dermatology, 153(3), 549-551. DOI:10.1111/j.1365-2133.2005.06728.x
    . Publication link: 6a18cf74-1082-4e00-8a23-399d3a55a727
  • Hinks, A., Barton, A., John, S., Bruce, I., Hawkins, C., Griffiths, C. E. M., ... Worthington, J. (2005). Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: Further support that PTPN22 is an autoimmunity gene. Arthritis and Rheumatism, 52(6), 1694-1699. DOI:10.1002/art.21049
    . Publication link: e8b09096-1166-4032-9ba5-95a207fa1bff
  • Ho, P., Bruce, I. N., Silman, A., Symmons, D., Newman, B., Young, H., ... Barton, A. (2005). Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis and Rheumatism, 52(11), 3596-3602. DOI:10.1002/art.21393
    . Publication link: af385c21-9987-4acd-a736-3ee4adf15f1b
  • Kyle, S., Chandler, D., Griffiths, C. E. M., Helliwell, P., Lewis, J., McInnes, I., ... McHugh, N. (2005). Guideline for anti-TNF-α therapy in psoriatic arthritis. Rheumatology, 44(3), 390-397. DOI:10.1093/rheumatology/keh514
    . Publication link: 16983a51-9581-4b4e-9ed0-91e6e49da1a2
  • Langley, R. G. B., Krueger, G. G., & Griffiths, C. E. M. (2005). Psoriasis: Epidemiology, clinical features, and quality of life. Annals of the Rheumatic Diseases, 64(2), 18-23. DOI:10.1136/ard.2004.033217
    . Publication link: adb6e34a-149e-454f-8a9b-0777c677ded8
  • Lovatt, T. J., Lear, J. T., Bastrilles, J., Wong, C., Griffiths, C. E. M., Samarasinghe, V., ... Strange, R. C. (2005). Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors.Journal of the American Academy of Dermatology, 52(3), 468-473. DOI:10.1016/j.jaad.2004.08.060
    . Publication link: 8a782f3e-466d-47fa-87a8-3f011a6b392a
  • Murray, A. K., Herrick, A. L., Moore, T. L., King, T. A., & Griffiths, C. E. M. (2005). Dual wavelength (532 and 633 nm) laser Doppler imaging of plaque psoriasis. British Journal of Dermatology, 152(6), 1182-1186. DOI:10.1111/j.1365-2133.2005.06479.x
    . Publication link: e0e2e74b-2232-45c9-9654-3d9c381a6773
  • Naldi, L., & Griffiths, C. E. M. (2005). Traditional therapies in the management of moderate to severe chronic plaque psoriasis: An assessment of the benefits and risks. British Journal of Dermatology, 152(4), 597-615. DOI:10.1111/j.1365-2133.2005.06563.x
    . Publication link: 6f9cd103-3bcd-4f7f-8404-7e903bb0c416
  • Papp, K. A., Tyring, S., Lahfa, M., Prinz, J., Griffiths, C. E. M., Nakanishi, A. M., ... Van De Kerkhof, P. C. M. (2005). A global phase III randomized controlled trial of etanercept in psoriasis: Safety, efficacy, and effect of dose reduction. British Journal of Dermatology, 152(6), 1304-1312. DOI:10.1111/j.1365-2133.2005.06688.x
    . Publication link: 411999e0-a4d1-49a5-a391-e90edbf5f911
  • Quekenborn-Trinquet, V., Fogel, P., Aldana-Jammayrac, O., Ancian, P., Demarchez, M., Rossio, P., ... Griffiths, C. E. M. (2005). Gene expression profiles in psoriasis: Analysis of impact of body site location and clinical severity. British Journal of Dermatology, 152(3), 489-504. DOI:10.1111/j.1365-2133.2005.06384.x
    . Publication link: c64e5c9f-8c89-49b4-afb8-0c0ddb560e1b
  • Richards, H. L., Griffiths, C. E. M., Fortune, D., & Main, C. J. (2005). Alexithymia patients with psoriasis; clinical correlates and psychometric properties of the TAS-20. Journal of Psychosomatic Research, 58.
    . Publication link: 245cf286-037e-40e5-98c2-383fff0dea32
  • Richards, H., Fortune, D. G., Richards, H. L., & Griffiths, C. E. M. (2005). Psychologic factors in psoriasis: Consequences, mechanisms, and interventions. Dermatologic Clinics, 23(4), 681-694. DOI:10.1016/j.det.2005.05.022
    . Publication link: 20c53591-2d48-44bd-862e-a859860887cb
  • Richards, H., Fortune, D. G., Richards, H. L., Griffiths, C. E. M., & Main, C. J. (2005). Adversarial growth in patients undergoing treatment for psoriasis: A prospective study of the ability of patients to construe benefits from negative events. Psychology, Health and Medicine, 10(1), 44-56. DOI:10.1080/13548500512331315352
    . Publication link: 8a0fe37b-818f-41b8-ab6a-4ef10c6ad7f7
  • Richards, H., Fortune, D. G., Richards, H. L., Griffiths, C. E. M., & Main, C. J. (2005). Worry and pathological worry in patients with psoriasis: Cross sectional and longitudinal analyses of the Penn State Worry Questionnaire (PSWQ) in four samples of patients. Journal of Clinical Psychology in Medical Settings, 12(2), 143-152. DOI:10.1007/s10880-005-3274-9
    . Publication link: fc260244-62b8-487f-8c39-52f90b605e4e
  • Richards, H., Richards, H. L., Ray, D. W., Kirby, B., Mason, D., Plant, D., ... Griffiths, C. E. M. (2005). Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. British Journal of Dermatology, 153(6), 1114-1120. DOI:10.1111/j.1365-2133.2005.06817.x
    . Publication link: 04c4b2ae-a017-48b6-b7f4-447bf75ddb71
  • Van De Kerkhof, P., Griffiths, C. E. M., Christophers, E., Lebwohl, M., & Krueger, G. G. (2005). Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate. Dermatology, 211(3), 256-263. DOI:10.1159/000087020
    . Publication link: 9ffa50d6-9b02-44d3-aeb9-08d7a13cd3fa
  • Warren, R. B., & Griffiths, C. E. M. (2005). The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasis. British Journal of Dermatology, 153(5), 869-873. DOI:10.1111/j.1365-2133.2005.06880.x
    . Publication link: 38b1a4cb-96b8-4b04-922f-643fcc01362b | PubMed:16225593
  • Griffiths, C. E. M., & Mendonca, C. (2005). Psoriasis: future drugs. In Medicine. (Vol. 33:1). Academic Press.
    . Publication link: 928a9b66-d8bd-402c-8105-9016825fad90
  • Seston, E. M., Ashcroft, D. M., & Griffiths, C. E. M. (2005). Examining patients' preferences for the treatment of psoriasis.(Final report, University of Manchester: School of Pharmacy & Pharmaceutical Sciences). No publisher name.
    . Publication link: a4e5be45-73ff-4f61-ae24-6628c8709598
  • Griffiths, C. E. M., Winhoven, S. M., Blackburn, A., & Gibbs, N. K. (2005). Paul Langerhans: the man and 'his' cell.In British Journal of Dermatology. (Vol. 153). Academic Press.
    . Publication link: 2cdd598a-331d-48f5-9e61-1036469e7d30

2004

2003

  • Asumalahti, K., Ameen, M., Suomela, S., Hagforsen, E., Michaëlsson, G., Evans, J., ... Barker, J. N. W. N. (2003). Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. Journal of Investigative Dermatology, 120(4), 627-632. DOI:10.1046/j.1523-1747.2003.12094.x
    . Publication link: f7fc97e9-01f7-49fa-9eec-ee92044d899e
  • Barker, J. N. W. N., Berth-Jones, J., Groves, R., Omerod, A. D., Rizova, E., & Griffiths, C. E. M. (2003). Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3 μg/g ointment; no correlation with extent of psoriasis. Journal of Dermatological Treatment, 14(1), 14-21. DOI:10.1080/09546630305543
    . Publication link: 9039a5d1-2ff9-4df6-b31b-370b2f0f1b27
  • Cameron, A. L., Kirby, B., & Griffiths, C. E. M. (2003). Circulating natural killer cells in psoriasis. British Journal of Dermatology, 149(1), 160-164. DOI:10.1046/j.1365-2133.2003.05319.x
    . Publication link: fe798edd-2ea6-4ca1-8882-3accfdd8a437
  • Chalmers, R. J. G., & Griffiths, C. E. M. (2003). Resetting the research agenda for psoriasis. Journal of Investigative Dermatology, 120(5), x-x. DOI:10.1046/j.1523-1747.2003.12152.x
    . Publication link: 1632b0ef-7688-4b9f-9d4d-3cd3fd601391
  • Cumberbatch, M., Bhushan, M., Dearman, R. J., Kimber, I., & Griffiths, C. E. M. (2003). IL-1β-induced Langerhans' cell migration and TNF-α production in human skin: Regulation by lactoferrin. Clinical and Experimental Immunology, 132(2), 352-359. DOI:10.1046/j.1365-2249.2003.02146.x
    . Publication link: b351090f-e610-4baa-b524-deaf2b6ece61 | PubMed:12699428
  • Cumberbatch, M., Dearman, R. J., Griffiths, C. E. M., & Kimber, I. (2003). Epidermal Langerhans cell migration and sensitisation to chemical allergens. APMIS, 111(7-8), 797-804. DOI:10.1034/j.1600-0463.2003.11107811.x
    . Publication link: 8ec4dc83-3513-4b9d-8ec8-a54072aaeaf5 | PubMed:12974781
  • Fortune, D. G., Richards, H. L., Kirby, B., McElhone, K., Markham, T., Rogers, S., ... Griffiths, C. E. M. (2003). Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Archives of Dermatology, 139(6), 752-756. DOI:10.1001/archderm.139.6.752
    . Publication link: be93ed65-cc8e-416a-b9a2-e2150db79d20
  • Griffiths, C. E. M. (2003). The immunological basis of psoriasis. Journal of the European Academy of Dermatology and Venereology, 17(2), 1-5. DOI:10.1046/j.1468-3083.17.s2.1.x
    . Publication link: a328ce92-42b8-41c4-a240-2ad5e6fea8a1
  • Griffiths, C. E. M., & Young, H. (2003). New biological response modifiers for inflammatory skin disease. Postgraduate Doctor Caribbean, 19.
    . Publication link: 604a1703-9b4f-4d9f-9ecf-520dbdecc0ab
  • Griffiths, C. E. M., & Young, H. (2003). Treatment resistance in psoriasis. Doctor.
    . Publication link: 3572614d-8ced-48da-892b-52ebc2bc6b4a
  • Kang, S., Goldfarb, M. T., Weiss, J. S., Metz, R. D., Hamilton, T. A., Voorhees, J. J., & Griffiths, C. E. M. (2003). Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: A randomized trial. Journal of the American Academy of Dermatology, 49(1), 83-90. DOI:10.1067/mjd.2003.451
    . Publication link: 29234d56-5d2d-4922-9f37-f58c133ce03a
  • Lebwohl, M., Christophers, E., Langley, R., Ortonne, J. P., Roberts, J., & Griffiths, C. E. M. (2003). An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Archives of Dermatology, 139(6), 719-727. DOI:10.1001/archderm.139.6.719
    . Publication link: 6230c4ed-5078-4960-8e1d-9665ef0c5be1
  • Ling, T. C., Herrick, A. L., Andrew, S. M., Brammah, T., & Griffiths, C. E. M. (2003). Keloidal scleroderma. Clinical and Experimental Dermatology, 28(2), 171-173. DOI:10.1046/j.1365-2230.2003.01220.x
    . Publication link: b4279b65-7289-41f5-a1f6-6d6d82ad2094
  • Little, M. C., Griffiths, C. E. M., Watson, R. E. B., Pemberton, M. N., & Thornhill, M. H. (2003). Oral mucosal keratinocytes express RANTES and ICAM-1, but not interleukin-8, in oral lichen planus and oral lichenoid reactions induced by amalgam fillings. Clinical and Experimental Dermatology, 28(1), 64-69. DOI:10.1046/j.1365-2230.2003.01158.x
    . Publication link: 03dc8593-8b50-4e80-b121-ab8046e7f5f1
  • McKenna, S. P., Cook, S. A., Whalley, D., Doward, L. C., Richards, H. L., Griffiths, C. E. M., & Van Assche, D. (2003). Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. British Journal of Dermatology, 149(2), 323-331. DOI:10.1046/j.1365-2133.2003.05492.x
    . Publication link: b6fc4af0-3835-4875-ad9b-43ed9b5776f8
  • Ortonne, J. P., Lebwohl, M., Em Griffiths, C., Barber, K., Murray, E., Bourcier, M., ... Nigra, T. (2003). Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis. European Journal of Dermatology, 13(2), 117-123.
    . Publication link: b367466c-0b6c-4685-95c8-7eb5605e1423
  • Richards, H. L., Fortune, D. G., Main, C. J., & Griffiths, C. E. M. (2003). Stigmatization and psoriasis [10]. British Journal of Dermatology, 149(1), 209-211. DOI:10.1046/j.1365-2133.2003.05391.x
    . Publication link: 2555d23c-08cc-44b6-ace1-4941842b7e26
  • Richards, H., Fortune, D. G., Richards, H. L., Corrin, A., Taylor, R. J., Griffiths, C. E. M., & Main, C. J. (2003). Attentional bias for psoriasis-specific and psychosocial threat in patients with psoriasis. Journal of Behavioral Medicine, 26(3), 211-224. DOI:10.1023/A:1023408503807
    . Publication link: 2eeed347-6b3f-4df7-894b-0b2b1d53bb2d
  • Wong, C. L., Houghton, J. B., Andrew, S., & Griffiths, C. E. M. (2003). Papuloerythroderma of Ofuji associated with acute myeloid leukaemia. Clinical and Experimental Dermatology, 28(3), 277-279. DOI:10.1046/j.1365-2230.2003.01260.x
    . Publication link: cdfc75c3-c557-4319-bb74-6a1cd13ddede
  • Young, C., Allen, M. H., Cuthbert, A., Ameen, M., Veal, C., Leman, J., ... Barker, J. N. W. N. (2003). A Crohn's disease-associated insertion polymorphism (3020insC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo-plantar pustular psoriasis or guttate psoriasis. Experimental Dermatology, 12(4), 506-509. DOI:10.1034/j.1600-0625.2002.120420.x
    . Publication link: 2b4041dc-2299-4aa8-b38d-caa70e6139db
  • Young, H., & Griffiths, C. E. M. (2003). Immunotherapy in Psoriasis. Giornale Italiano di Dermatologia e Venereologia, 138.
    . Publication link: aa44ac58-e2a2-468a-afdd-5940cdd46ae3
  • Griffiths, C. E. M., Watson, R. E. B., Walker, J. M., Hoare, L. M., & O'Neill, C. A. (2003). Claudin expression in healthy skin and chronic plaque psoriasis. In British Journal Of Dermatology. (Vol. 148)
    . Publication link: e04d21bf-73ad-4c30-8f4c-839231b4d2cb

2002

2001

2000

  • Ashcroft, D. M., Po, A. L. W., Williams, H. C., & Griffiths, C. E. M. (2000). Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol: In the treatment of mild to moderate plaque psoriasis. Pharmacoeconomics, 18(5), 469-476.
    . Publication link: 1e7afadb-3f73-4444-b3f6-b19b94f4e1c6
  • Bhushan, M., Moore, T., Herrick, A. L., & Griffiths, C. E. M. (2000). Nailfold video capillaroscopy in psoriasis. British Journal of Dermatology, 142(6), 1171-1176. DOI:10.1046/j.1365-2133.2000.03544.x
    . Publication link: e213b63f-356e-4e7f-a969-f64dadd76a7f
  • Fortune, D. G., Richards, H. L., Main, C. J., & Griffiths, C. E. M. (2000). Pathological worrying, illness perceptions and disease severity in patients with psoriasis. British Journal of Health Psychology, 5(1), 71-82.
    . Publication link: f0eb6fab-a33c-4e73-b329-e9abebd0f1e9
  • Griffiths, C. E. M., Ashcroft, D. M., Li, W. P. A., & Williams, H. C. (2000). Combination regimens of topical calcipotriol in chronic plaque psoriasis: A systematic review of their efficacy and tolerability. Archives of Dermatology, 136.
    . Publication link: e042cf00-29c8-4403-af81-1983297075d9
  • Griffiths, C. E. M., Ashcroft, D. M., Li, W. P. A., & Williams, H. C. (2000). Systematic review of comparative efficacy and tolerability of calcipotriol in the treatment of chronic plaque psoriasis. British Medical Journal, 320.
    . Publication link: acad6583-b881-4ffa-b896-74155986eb04
  • Griffiths, C. E. M., Kirby, B., Fortune, D., Bhushan, M., & Chalmers, R. J. G. (2000). The Salford Psoriasis Index (SPI): an holistic measure of psoriasis severity.Br J Dermatol, 142.
    . Publication link: f02b5a92-0372-45b3-8148-d12a3c39d1f4
  • Harrison, B., Herrick, A., & Griffiths, C. (2000). Psoriasis and diffuse systemic sclerosis: A report of three patients. Rheumatology, 39(2), 213-215.
    . Publication link: 83c60e7e-1cc5-4cdc-b3f9-65aa25029172
  • Kimber, I., Cumberbatch, M., Dearman, R. J., Bhushan, M., & Griffiths, C. E. M. (2000). Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. British Journal of Dermatology, 142(3), 401-412. DOI:10.1046/j.1365-2133.2000.03349.x
    . Publication link: 13ccb354-0ef5-422c-8a94-4d30df6fcff3 | PubMed:10735943
  • Kimber, I., Cumberbatch, M., Dearman, R. J., Bhushan, M., & Griffiths, C. E. M. (2000). Mobilization of epidermal Langerhans cells - Reply from the authors [3]. British Journal of Dermatology, 143(4), 894.
    . Publication link: f3f0d741-0e12-428d-9685-b256ad733fa1 | PubMed:11069482
  • Kirby, B., Al-Jiffri, O., Cooper, R. J., Corbitt, G., Klapper, P. E., & Griffiths, C. E. M. (2000). Investigation of cytomegalovirus and human herpes viruses 6 and 7 as possible causative antigens in psoriasis. Acta Dermato-Venereologica, 80(6), 404-406. DOI:10.1080/000155500300012738
    . Publication link: 80ddc9ad-fdac-42e7-b079-16685a09ba09

1999

  • Ashcroft, D. M., Li Wan Po, A., Williams, H. C., & Griffiths, C. E. M. (1999). Clinical measures of disease severity and outcome in psoriasis: A critical appraisal of their quality. British Journal of Dermatology, 141(2), 185-191. DOI:10.1046/j.1365-2133.1999.02963.x
    . Publication link: ff732b05-fa1c-47c7-8075-99c4152b5f74
  • Richards, H. L., Fortune, D. G., O'Sullivan, T. M., Main, C. J., & Griffiths, C. E. M. (1999). Patients with psoriasis and their compliance with medication. Journal of the American Academy of Dermatology, 41(4), 581-583.
    . Publication link: 2778184d-a982-4d39-8076-9954c2b4d2ce
  • Watson, R. E. B., Griffiths, C. E. M., Craven, N. M., Shuttleworth, C. A., & Kielty, C. M. (1999). Fibrillin-rich microfibrils are reduced in photoaged skin. Distribution at the dermal-epidermal junction. Journal of Investigative Dermatology, 112(5), 782-787. DOI:10.1046/j.1523-1747.1999.00562.x
    . Publication link: 6188c09e-e6da-489d-b755-c5d37000fc62

1998

  • Fortune, D. G., Richards, H. L., Main, C. J., & Griffiths, C. E. M. (1998). What patients with psoriasis believe about their condition. Journal of the American Academy of Dermatology, 39(2 I), 196-201. DOI:10.1016/S0190-9622(98)70074-X
    . Publication link: a218c0f9-51eb-4013-a566-fd4acf8da207
  • Gilmour, E., Campbell, S. M., Loane, M. A., Esmail, A., Griffiths, C. E. M., Roland, M. O., ... Wootton, R. (1998). Comparison of teleconsultations and face-to-face consultations: Preliminary results of a United Kingdom multicentre teledermatology study. British Journal of Dermatology, 139(1), 81-87. DOI:10.1046/j.1365-2133.1998.02318.x
    . Publication link: b77920c1-1bca-4088-9e4e-ab3f4a548b91
  • Griffiths, C. E. M., Ancian, P., Humphries, J., Poncet, M., Rizova, E., Michel, S., & Clucas, A. (1998). Adapalene 0.1% gel and adapalene 0.1% cream stimulate retinoic acid receptor mediated gene transcription without significant irritative effects in the skin of healthy human volunteers. British Journal of Dermatology, Supplement, 139(52), 12-16.
    . Publication link: 0f9760e8-74bc-4cff-8a05-8564efd3b10d | PubMed:9990415
  • Humphries, J. D., Parry, E. J., Watson, R. E. B., Garrod, D. R., & Griffiths, C. E. M. (1998). All-trans retinoic acid compromises desmosome expression in human epidermis. British Journal of Dermatology, 139(4), 577-584. DOI:10.1046/j.1365-2133.1998.02451.x
    . Publication link: f18bea1e-bd58-45c7-8420-f53e92acdf8a | PubMed:9892899
  • Richards, H. L., Griffiths, C. E. M., Fortune, D. G., Main, C. J., TM, O., & Sullivan, . U. (1998). Developing clinical psychology services in an outpatient dermatology specialist clinic. Clinical Psychology Forum, 115.
    . Publication link: 4188f9d0-5625-4820-a75e-0e0d6b9cd848
  • Watson, R. E. B., Parry, E. J., Humphries, J. D., Jones, C. J. P., Polson, D. W., Kielty, C. M., & Griffiths, C. E. M. (1998). Fibrillin microfibrils are reduced in skin exhibiting striae distensae. British Journal of Dermatology, 138(6), 931-937. DOI:10.1046/j.1365-2133.1998.02257.x
    . Publication link: 8f15beb7-78f6-441a-aded-7e3e6d19c981 | PubMed:9747352